Medtronic President Michael Marinaro Receives Annual Equity Incentive Awards

Transaction Summary

On November 2, 2026, Michael Marinaro, President at Medtronic plc ($MDT), received routine long-term equity incentive grants consisting of non-derivative and derivative awards:

1. Restricted Stock Units (RSUs): Granted 6,547 Ordinary Shares at an acquisition price of $0.00 per share. These units vest 100% on August 3, 2029. Following this transaction, Marinaro directly owns 113,353 ordinary shares (including 890 shares acquired via dividend reinvestment).
2. Performance Share Units (PSUs): Awarded 16,367 PSUs at target (with potential vesting ranging from 0 to 39,281 shares depending on performance metrics over a three-year period ending April 27, 2029).
3. Stock Options: Awarded 42,994 stock options with an exercise price of $99.29 per share, expiring November 2, 2036. The options vest at 25% annually beginning August 3, 2027.

Market & Trading Significance

This filing reflects standard executive compensation awards (Transaction Code 'A') rather than open-market purchases or sales. Because these awards are scheduled grants as part of the company's executive equity incentive program, they represent Low trading significance and do not indicate discretionary open-market sentiment.